alexa Abstract | A Validated RP - HPLC Method for Simulataneous Estimation of Emtricitabine and Tenofovir Disoproxil Fumarate in Pure and in Tablet Dosage Form

Der Pharmacia Sinica
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article Open Access


A simple, rapid reverse - phase high performance liquid chromatographic method has been developed and validated for the simultaneous estimation of emtricitabine and tenofovir disoproxil fumarate in pure and in tablet dosage form. The estimation was carried out on a Phenomenax Luna C18 (150 mm x 4.6 mm i.d., particle size 5μm) column with a mixture of acetonitrile: methanol: water in the ratio of 30:50:20 (v/v) as mobile phase. UV detection was performed at 258 nm. The method was validated for linearity, accuracy, precision, specificity and sensitivity as per ICH norms. The developed and validated method was successfully used for the quantitative analysis of commercially available dosage form. The retention time was 2.77 and 3.49 min. for emtricitabine and tenofovir disoproxil fumarate, respectively. The flow rate was 0.6 mL/ min. The calibration curve was linear over the concentration range of 2 –12 μg mL-1 for emtricitabine and 1-6 μg/ mL for tenofovir disoproxil fumarate. The LOD and LOQ values were found to be 0.03003 and 0.091015 mg/ mL for emtricitabine and 1.4270 and 4.3243mg/ mL for tenofovir disoproxil fumarate, respectively. The high percentage of recovery and low percentage coefficient of variance confirm the suitability of the method for the simultaneous estimation of emtricitabine and tenofovir disoproxil fumarate in pure and in tablet dosage form.

To read the full article Peer-reviewed Article PDF image

Author(s): Anandakumar Karunakaran Kannan Kamarajan and Vetrichelvan Thangarasu


Emtricitabine, Tenofovir disoproxil fumarate, RP-HPLC, Validation.

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version